Herpes Gister vaccine reduces the risk of dementia by 20%

A new study found that elderly adults who vaccinate herpes gestor may have the risk of creating dementia Posted ‘Nature’.

The study is, Made in WalesThere are about 283,000 adults. Some of them are not considered worthy of vaccination due to a uniqueness in the Welsh region’s vaccine policy. In 2013, the Cardiff government decided that those who reached the age of 79 could get vaccinated. However, due to shortage of goods, Adults who are already 80 years old or adults who don’t get it.

But researchers from the United States, Germany and Austria focused on those who reached the age of 80 in the pre -vaccine deadline, and compared to those who reached 80 next week. Approximately half of those who have met the need for vaccination. After seven years, one of the eight people who were not vaccinated suffered from aging. However, Vaccines are likely to be infected with dementia 20% less than 20%According to the study.

The effects were too high Among women More than men. Pascal Geldsetzer, a prominent writer and medical professor of Stanford University (USA), said in a statement: “The discovery was really amazing. This was a great security signalThey will see how the data will be viewed. ”

Other studies have suggested that herpes Gister vaccine can help keep Dementia in the Gulf. Last year, Another analysis Published in ‘Nature Medicine’, the most recent version of the Herpes Jester vaccine showed that the risk of creating dementia is significantly In six years after his vaccine.

Both vaccines are made differently. New, more common, a Joster Chicken Box Virus Protein, It causes both chicken box and herpes. Welsh Study Vaccine a Weak virus version. By 2023, the United Kingdom gradually eliminated the virus vaccine in favor of the most recent GSK drug vaccine, as it seems to provide security against Gister for a long time.

Herpes Jester -The great virus is re -activated, the painful eruption of the fluid full of fluid that appears to the chicken box many years later. Elderly and people Weak immune system They are more dangerous.

Two recent studies are very similar to natural tests Random articlesThey are the golden rule of medical research. Due to the qualification criteria for the herpes Gister vaccine, researchers can compare two groups of other similar people, which allowed the potential impact of the vaccine. “What makes the study is more powerful is that this is basically a random article Control panel Are slightly rustic to put on a vaccine- and a Intervention -The person who is so young that can be vaccinated, “says Geldsetzer.

Need additional studies to prove the cause

Studies indicate that herpes Gister vaccine can be provided, regardless of the type of injection Some protection against dementiaAlthough there is no need for additional research to prove it. It is not clear about this relationship. The Keldsetzer group suggests that viruses affecting the nervous system will increase the risk of dementia, But this theory must be proven.

Meanwhile, the imbalance between Women and men It can explain it Differences in its immune system. “Although this is still fictional, we believe that we are related to the differences between men and women,” the Takett ‘Eurous Health “said.

GSK Drug Manufacturer announced last week to assist to confirm the tests 1.4 million adults in the United KingdomSome of them were vaccinated against herpes Gister and others. Like the change in the policy of Wales, in 2023, the United Kingdom expanded its vaccine program against her herpes zoster for adults over 65 years, but it was then said that the 66 to 69 -year -olds had to wait up to 70.

In another natural examination, researchers check whether dementia develops. The latest findings about Herpes Gister vaccine refer to a new border Alzheimer’s researchThere has been difficulty in its prevention or new treatment for decades.

Alzheimer’s disease is the most common way of dementia, which affects it Seven million people in EuropeAccording to the estimates of the European Brain Council. “Dementia is a huge burden,” says Takette. “The implementation of the immune system that is appropriate for the people can reduce or invest in the process of dementia,” he said. “There are many, many steps between the place we are now, but I think this is a new and wonderful song in this field.”